However, both PDK1 and AKT kinases, which might be expected to be upregulated in KRAS-mutant lung cancers due to Kras protein interaction with PI3-kinase, did not show any significant phosphorylation activation in KRAS-mutant tumors (Supplementary Table 1). The gene discussed is KRAS; the disease is lung carcinoma.